Trial Profile
A Prospective, Non randomised Trial To Assess Inhibitory Mechanisms of Very Low Dose Rivaroxaban in Non-St-Elevation Myocardial Infarction Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Aspirin; Clopidogrel; Ticagrelor
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology
- 08 May 2018 New trial record
- 12 Mar 2018 Results presented at the 67th Annual Scientific Session of the American College of Cardiology